AzTrials
AzTrials

DystoniaPhase 3NCT00169403

Pallidal Stimulation in Patients With Idiopathic Generalised Dystonia

A Phase 3 study testing Deep brain stimulation in people with Dystonia, run by Groupe Hospitalier Pitie-Salpetriere at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Pallidal stimulation is effective in patients with generalised idiopathic dystonia. The aim of this study is to: 1. evaluate the efficacy and safety of this treatment in patients with idiopathic generalised dystonia, 3 years after surgery and 2. assess the recurrence of the motor symptoms after the switch off. Read more about this study

Who is it for?
Ages 15 to 65 years
Conditions the study is for
Dystonia
What is being tested?
Deep brain stimulation
Type of treatment
Surgery or procedure
How many people
Not given
Where
1 siteFrance
Study dates
Start not givento not given
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 to 65 years
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Idiopathic generalised dystonia
  • Pallidal stimulation

Who cannot join

  • Mini-mental status (MMS) < 24
  • Severe psychiatric disorder

Trial locations and contacts

1 site in 1 country.

Marie Vidailhet, MD, PhD contact

33-142161950

marie.vidailhet@sat.ap-hop-paris.fr

Marie-Laure Welter, MD contact

33-142161950

marie-laure.welter@psl.aphp.fr

France1 site, 1 recruiting
  • Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere

    Paris

    Marie-Laure Welter, MD, 33-142161950, marie-laure.welter@psl.aphp.fr

    Marie Vidailhet, MD, PhD

    Recruiting

Other trials in France

About this study

Pallidal stimulation is effective in patients with generalised idiopathic dystonia. The aim of this study is to:

  1. evaluate the efficacy and safety of this treatment in patients with idiopathic generalised dystonia, 3 years after surgery and
  2. assess the recurrence of the motor symptoms after the switch off.
Conditions
Dystonia
Being tested
Deep brain stimulation
Keywords
Idiopathic dystonia, deep brain stimulation, globus pallidus, generalised Idiopathic dystonia
Medical subject headings
Dystonia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Deep brain stimulationProcedure or surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2005 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00169403
Sponsor's protocol ID
P000201
Status last verified
Sep 2005
First submitted
12 Sep 2005
Last updated
29 Aug 2007
Results posted
No

Publications

  • Vidailhet M, Vercueil L, Houeto JL, Krystkowiak P, Benabid AL, Cornu P, Lagrange C, Tezenas du Montcel S, Dormont D, Grand S, Blond S, Detante O, Pillon B, Ardouin C, Agid Y, Destee A, Pollak P; French Stimulation du Pallidum Interne dans la Dystonie (SPIDY) Study Group. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005 Feb 3;352(5):459-67. doi: 10.1056/NEJMoa042187.

    PubMed 15689584

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Deep brain stimulation in people with Dystonia, run by Groupe Hospitalier Pitie-Salpetriere at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Aug 2007. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Marie Vidailhet, MD, PhD (33-142161950, marie.vidailhet@sat.ap-hop-paris.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00169403, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Aug 2007.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in